Article
BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods.
Journal of clinical pathology - 1 Nov 2017
O'Brien Odharnaith, Lyons Tomas, Murphy Sandra, Feeley Linda, Power Derek, Heffron Cynthia C B B
Abstract excerpt
AIMS: The assessment of B-raf proto-oncogene, serine/threonine kinase (BRAF) gene status is now standard practice in patients diagnosed with metastatic melanoma with its presence predicting a clinical response to treatment with BRAF inhibitors. The gold standard in determining BRAF status is curr...
Topics
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- DNA Mutational Analysis
- Genetic Predisposition to Disease
- Humans
- Immunohistochemistry
- Ireland
- Melanoma
- Middle Aged
